| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/10/2002 | WO2002022600A3 Chemokine receptor binding heterocyclic compounds |
| 05/10/2002 | WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them |
| 05/10/2002 | WO2002000339A3 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | CA2427911A1 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055045 Novel materials useful as electrolytic solutes |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202978A1 Isoxazolyl- and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP1202728A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | EP0723545B1 Quinolizinone type compounds |
| 05/08/2002 | DE10054482A1 Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists |
| 05/08/2002 | CN1348449A Heteroaryl diazacycloalkanes, their preparation and use |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1348439A New compounds, their preparation and use |
| 05/08/2002 | CN1348436A Novel ligands of nuclear receptors PPAR's |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6384063 Compound having effect of promoting neuron differentiation |
| 05/07/2002 | US6384060 2,4,6-trisbstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof |
| 05/07/2002 | US6384058 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof |
| 05/07/2002 | US6384057 Compounds as estrogens for treatment of deficiency |
| 05/07/2002 | US6384039 QT dispersion and heart rate variability improvement with CRF antagonists to prevent sudden death |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia |
| 05/07/2002 | US6384033 Drugs for vision defects |
| 05/07/2002 | US6383986 Use as herbicides, desiccants or defoliants and plant safening agents |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034720A1 Process for preparing vinyl-substituted heterocycles |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2002034708A2 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/02/2002 | WO2001096283A3 Hiv integrase inhibitors |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001085675A3 Fluorous tagging compounds and their use |
| 05/02/2002 | WO2001070733A3 Di-substituted iminoheterocyclic compounds |
| 05/02/2002 | WO2001064642A3 Benzamides and related inhibitors of factor xa |
| 05/02/2002 | WO2001052829A3 Statin-type bone growth stimulators |
| 05/02/2002 | WO2000076977A3 Oxidation colorant starting products |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052509 Calcilytic compounds and method of use |
| 05/02/2002 | US20020052508 Heterocyclic thioamide derivatives |
| 05/02/2002 | US20020052507 Process for making 3-amino-2-chloro-4-methylpyridine |
| 05/02/2002 | US20020052497 Compounds capable of activating cholinergic receptors |
| 05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 05/02/2002 | US20020052401 Benzophenones and sulfones as inhibitors of glycine uptake |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052393 Benzanilides as potassium channel openers |
| 05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 05/02/2002 | US20020052343 Salicylamides as serine protease inhibitors |
| 05/02/2002 | US20020052295 Killing, controlling growth of or eliciting symptoms of phytotoxicity in plants. |
| 05/02/2002 | US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| 05/02/2002 | US20020051278 Electrochromic media for producing a preselected color and devices comprising same |
| 05/02/2002 | EP1201655A2 Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides |
| 05/02/2002 | EP1201235A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 05/02/2002 | EP1200420A1 Process for making n-alkyl bis(thiazolyl)sulfenimides |
| 05/02/2002 | EP1200413A1 Trifluoromethylpyri(mi)dine carboxamides |
| 05/02/2002 | EP1200411A2 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200397A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments |
| 05/02/2002 | EP1200396A1 Naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200076A1 Calcilytic compounds |
| 05/02/2002 | EP1140843A4 Improved pyridine/picoline production process |
| 05/02/2002 | EP0859781B1 Lithium and pyridine hexafluorophosphate solvate, its preparation and method for preparing lithium hexafluorophosphate using this solvate |
| 05/02/2002 | CA2426741A1 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 05/01/2002 | CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 05/01/2002 | CN1083690C Method of combatting insect eggs |
| 04/30/2002 | US6380393 Complex containing pyrazole ring |
| 04/30/2002 | US6380392 Complexes |
| 04/30/2002 | US6380391 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 04/30/2002 | US6380386 Insecticides, bactericides |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |